
|Articles|April 1, 2004
Supplements and Featured Publications
- Newsletter - Inflammation, Metabolic Syndrome, and CV Risk Reduction
- Volume 10
- Issue 1 Metab
Inflammation, Metabolic Syndrome, and CV Risk Reduction
Advertisement
Articles in this issue
over 21 years ago
Traditional CV risk factors: Necessary, but are they sufficient?Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
3
Real-World Data Key to Optimizing CAR T-Cell Therapy Delivery, Outcomes
4
Cancer Care in Transition: Navigating Breakthrough Therapies Amid Economic Strain
5














































